GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Argenica Therapeutics Ltd (ASX:AGN) » Definitions » Cash Receipts from Securities Related Activities

Argenica Therapeutics (ASX:AGN) Cash Receipts from Securities Related Activities


View and export this data going back to 2021. Start your Free Trial

What is Argenica Therapeutics Cash Receipts from Securities Related Activities?

Cash Receipts from Securities Related Activities only applies to banks.


Argenica Therapeutics (ASX:AGN) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Argenica Therapeutics Ltd (ASX:AGN) » Definitions » Cash Receipts from Securities Related Activities
Traded in Other Exchanges
N/A
Address
117 Broadway, Unit 4, Nedlands, WA, AUS, 6009
Argenica Therapeutics Ltd is engaged in the development and commercialization of novel drug candidates. Its ARG007 drug improves outcomes in pre-clinical stroke models and is in the process of being verified for its safety and toxicology before commencing Phase 1 clinical trials in humans.